United Kingdom· GB-APID-24569411000001108
Sovaldi 400mg tablets
A sofosbuvir product containing sofosbuvir, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sofosbuvir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AP08 (sofosbuvir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Sofosbuvir · ATC J05AP08
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sofosbuvir costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sofosbuvir · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- FR France$0.30
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sofosbuvir
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AP08
- ATC class
- Sofosbuvir
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5391507140890
- gtin05391507145871
- gtin05391507145741
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for sofosbuvir.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sofosbuvir · interactions on record
10 records
- 4 severe
- 5 moderate
- 1 minor
Most severe, free to view
- LorlatinibL01ED05severe
- LorlatinibL01XE44severe
- EnzalutamideL02BB04severe
- ApalutamideL02BB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sofosbuvir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSOVALDIGILEAD SCIENCES CANADA INC
- BelgiumEpclusa 200 mg - 50 mgGilead Sciences Ireland UC
- CzechiaSOVALDIGilead Sciences Ireland UC, Carrigtohill
- IrelandEpclusa 200 mg/50 mg film-coated tabletsGilead Sciences Ireland UC
- United StatesSovaldiGilead Sciences, Inc.
- IcelandSovaldiGilead Sciences Ireland UC*
- NetherlandsSovaldi 150 mg, granulaatGilead Sciences Ireland UC
- PolandSovaldiGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sovaldi
- Liechtenstein · Sovaldi
- Norway · Sovaldi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/366b077f-889d-468c-bd0c-132549c571cd GET /v1/drugs/366b077f-889d-468c-bd0c-132549c571cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "24569411000001108",
"desc": "Sovaldi 400mg tablets (Gilead Sciences Ltd)",
"form": "Oral tablet",
"vpid": "24581011000001100",
"source": "dmd",
"vtm_id": "777582003",
"strength": "400 mg",
"substance": "Sofosbuvir",
"ingredient": "Sofosbuvir",
"supplier_code": "2572301000001107"
}See everything about sofosbuvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.